Sexual dysfunction related to psychotropic drugs: A critical review - Part I: Antidepressants

Pharmacopsychiatry

Volumn 46, Issue 5, 2013, Pages 191-199

  La Torre, A ^a   Giupponi, G ^b   Duffy, D ^b   Conca, A ^b  

^a Ospedale di Rovereto   (Italy)

^b S Maurizio Hospital   (Italy)

Author keywords

antidepressant drugs; sexual dysfunction; sexual side effects; treatment emergent sexual dysfunction

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GEPIRONE; IMIPRAMINE; ISOCARBOXAZID; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; REBOXETINE; SELEGILINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; VENLAFAXINE;

ANORGASMIA; ARTICLE; CINAHL; COCHRANE LIBRARY; EJACULATION; EJACULATION DISORDER; HUMAN; HYPOTHALAMUS; LIBIDO; MEDIAL FOREBRAIN BUNDLE; MEDICATION COMPLIANCE; MEDLINE; META ANALYSIS (TOPIC); ORGASM; ORGASM DISORDER; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUALITY; SIDE EFFECT; VENTRAL TEGMENTUM;

ANTIDEPRESSIVE AGENTS; HUMANS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84879981743     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0033-1345205     Document Type: Article

References (157)

1. Kessler R. C., Berglund P., Demler O. et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA: 2003; 289 3095 3105
2. Baldwin D. S. Depression and sexual dysfunction. Br Med Bull: 2001; 57 81 99
3. Balon R. Depression, antidepressants, and human sexuality. Prim Psychiatry: 2007; 14: 42-44 47 50
4. Balon R. SSRI-associated sexual dysfunction. Am J Psychiatry: 2006; 163 1504 1509
5. Balon R., Yeragani V. K., Pohl R. et al. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry: 1993; 54 209 212
6. Clayton A. H. Antidepressant-associated sexual dysfunction: a potentially avoidable therapeutic challenge. Prim Psychiatry: 2003; 10 55 61
7. Cohen S., Kühn K. U., Sträter B. et al. Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances. Nervenarzt: 2010; 81 1129 1139
8. Davidson JR T. Sexual dysfunction and antidepressant. Depression: 1995; 2 233 240
9. Waldinger M. D., Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychoparmacol: 1998; 13 S27 S33
10. Werneke U., Northey S., Bhugra D. Antidepressant and sexual dysfunction. Acta Psychiatr Scand: 2006; 114 384 397
11. Williams VS L., Edin H. M., Hogue S. L. et al. Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey. J Psychopharmacol: 2010; 24 489 496
12. Haberfellner E. M. Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials. Pharmacopsychiatry: 2007; 40 173 182
13. La Torre A. Impotenze sessuali indotte da psicofarmaci. In: Rifelli G., Rifelli G. eds. Impotenza maschile, femminile, di coppia. Roma Scione: 2010; 381 399
14. Taylor M. J. Strategies for managing antidepressant-induced sexual dysfunction: a review. Curr Psychiatry Rep: 2006; 8 431 436
15. Boyarsky B. K., Hirschfeld R. M. The management of medication-induced sexual dysfunction. Essent Psychopharmacol: 2000; 3 39 58
16. Stahl S. M. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. third edition. New York Cambridge University Press: 2008
17. Keltner N. L., McAfee K. M., Taylor C. L. Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care: 2002; 38 111 116
18. Clayton A., Keller A., McGarvey E. L. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord: 2006; 91 27 32
19. Serretti A., Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychoparmacol: 2009; 29 259 266
20. Serretti A., Chiesa A. Antidepressivi e disfunzione sessuale: epidemiologia, meccanismi e strategie di trattamento. Giornale Italiano di Psicopatologia: 2010; 16 104 113
21. Montgomery S. A., Baldwin D. S., Riley A. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord: 2002; 69 119 140
22. Rosen R. C. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry: 2003; 64 5 10
23. Rosen R. C., Lane R. M., Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol: 1999; 19 67 85
24. Sthal SM. The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response. J Clin Psychiatry: 2001; 62 80 81
25. Sthal S. M. The psychopharmacology of sex, Part 2: Effects of drugs on the 3 phases of the human sexual response. J Clin Psychiatry: 2001; 62 147 148
26. Montejo-Gonzales A. I., Llorca G., Izquierdo J. A. et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther: 1997; 23 176 194
27. Corona G., Ricca V., Bandini E. et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med: 2009; 6 1259 1269
28. Gitlin M. Sexual dysfunction with psychotropic drugs. Expert Opin Pharmacother: 2003; 4 2259 2269
29. Kennedy S. H., Fulton K. A., Bagby R. M. et al. Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry: 2006; 51 234 242
30. Ben Zion I. Z., Tessler R., Cohen L. et al. Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function. Mol Psychiatry: 2006; 11 782 786
31. Bishop J. R., Ellingrod V. L., Akroush M. et al. The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives. Hum Psychopharmacol: 2009; 24 207 215
32. Bishop J. R., Moline J., Ellingrod V. L. et al. Serotonin 2A-1438 G/A and G-Protein Beta 3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side effects. Neuropsychopharmacology: 2006; 31 2281 2288
33. Zourková A., Cesková E., Hadasová E. et al. Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity. J Sex Marital Ther: 2007; 33 343 355
34. Zourková A., Hadasová E. Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment. J Sex Marital Ther: 2002; 28 451 461
35. Harrison W. M., Rabkin J. G., Ehrhardt A. A. et al. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol: 1986; 6 144 149
36. Hekimian L. J., Freidhoff A. J., Deever E. A comparison of the onset of action and therapeutic efficacy of amoxapine and amitriptyline. J Clin Psychiatry: 1978; 39 633 637
37. Karp J. F., Frank E., Ritenour A. et al. Imipramine and sexual dysfunction during the long term treatment of recurrent depression. Neuropsychopharmacology: 1994; 11 21 27
38. Monteiro W. O., Noshirvani H. F., Marks I. M. et al. Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. Br J Psychiatry: 1987; 151 107 112
39. Althof S. E. Pharmacological treatment of rapid ejaculation. Psychiatr Clin North Am: 1995; 18 85 94
40. Althof S. E., Levine S. B., Corty E. W. et al. A double-bind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry: 1995; 56 402 407
41. Althof S. E., Resnick K., Levine S. et al. Early experience with clomipramine for rapid ejaculation. J Urol: 1995; 153 474A
42. Girgis S. M., El-Haggar S., El-Hermouzy S. A double-bind trial of clomipramine in premature ejaculation. Andrologia: 1982; 14 364 368
43. Kim S. C., Seo K. K. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urology: 1998; 159 425 427
44. La Torre A. Il trattamento psicofarmacologico dell'eiaculazione precoce: analisi della letteratura. Rivista di Sessuologia: 1999; 23 379 401
45. Rowland D. L., Tai W. L., Brummett K. et al. Predicting responsiveness to the tretment of rapid ejaculation with 25 mg clomipramine as needed. Int J Impot Res: 2004; 16 354 357
46. Segraves R. T., Saran A., Segraves K. et al. Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther: 1993; 19 198 200
47. Strassberg D. S., De Gouveia Brazao C. A., Rowland D. L. et al. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther: 1999; 25 89 101
48. Waldinger M. D., Zwindermann A. H., Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol: 2004; 46 510 516
49. Kulik F. A., Wilbu R. Case report of painful ejaculation as a side effect of amoxapine. Am J Psychiatry: 1982; 139 234 235
50. Noyes R., Garvey M. J., Cook B. L. et al. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. J Clin Psychiatry: 1989; 50 163 169
51. Herman J. B., Brotman A. W., Pollack M. H. et al. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry: 1990; 51 25 27
52. Jacobsen F. M. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry: 1992; 53 119 122
53. Patterson W. M. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry: 1993; 54 71
54. Zajecka J., Fawcett J., Schaff M. et al. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry: 1991; 52 66 68
55. Zajecka J., Mitchell S., Fawcett J. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull: 1997; 33 755 760
56. Montejo A. L., Llorca G., Izquierdo J. A. et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry: 2001; 62 10 21
57. Gregorian R. S., Golden K. A., Bahce A. et al. Antidepressant-induced sexual dysfunction. Ann Pharmacother: 2002; 36 1557 1589
58. Clayton A. H., Pradko J. F., Croft H. A. et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry: 2002; 63 357 366
59. Devane C. L. Comparative safety and tolerability of selective serotonin reuptake inhibitors. Hum Psychopharmacol: 1995; 10 185 193
60. Fava M., Rankin M. Sexual functioning and SSRIs. J Clin Psychiatry: 2002; 63 13 16
61. Ferguson J. M. The effects of antidepressants on sexual functioning in depressed patients: a review. J Clin Psychiatry: 2001; 62 22 34
62. Williams VS L., Baldwin D. S., Hogue S. L. et al. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 european countries: a cross-sectional patient survey. J Clin Psychiatry: 2006; 67 204 210
63. Kennedy S. H., Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol: 2009; 29 157 164
64. Schweitzer I., Maguire K., Ng C. Sexual side-effects of contemporary antidepressants: review. Aust N Z J Psychiatry: 2009; 43 795 808
65. Ashton A. K., Mahmood A., Iqbal F. Improvements in SSRI/SNRI-induced sexual dysfunction by switching to escitalopram. J Sex Marital Ther: 2005; 31 257 262
66. Reimherr F. W., Chuinard G., Cohn C. K. et al. Antidepressant efficacy of sertraline: a doubleblind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry: 1990; 51 18 27
67. Piazza L. A., Markowitz J. C., Kocsis J. H. et al. Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. Am J Psychiatry: 1997; 154 1757 1759
68. Smith D. M., Levitte S. S. Association of fluoxetine and return of sexual potency in three elderly man. J Clin Psychiatry: 1999; 54 317 319
69. Benazzi F. Involuntary sperm emission with fluoxetine. Can J Psychiatry: 1995; 40 431
70. Kaplan P. M. The use of serotoninergic uptake inhibitors in the treatment of premature ejaculation. J Sex Marital Ther: 1994; 20 321 324
71. Waldinger M. D. Lifelong premature ejaculation: from authorithy-based to evidence-based medicine. BJU Int: 2004; 93 201 207
72. Waldinger M. D., Zwindermann A. H., Schweitzer D. H. et al. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res: 2004; 16 369 381
73. Jannini E. A., McMahon C. G., Marcel D. et al. eds. Premature Ejaculation. From Etiology to Diagnosis and Treatment.: 2013; Springer-Verlag Italia
74. Clayton A. H., Zajecka J., Ferguson J. M. et al. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol: 2003; 18 151 156
75. Langworth S., Bodlund O., Agren S. Efficacy and tolerability of reboxetine compared with citalopram. J Clin Psychopharmacol: 2006; 26 121 127
76. Mucci M. Reboxetine: a review of antidepressant tolerability. J Psychopharmacol: 1997; 11 S33 S37
77. Baldwin D., Bridgman K., Buis C. Resolution of sexual dysfunction during double blind treatment of major depression with reboxetine or paroxetine. J Psychopharmacol: 2006; 20 91 96
78. Kennedy S. H., Eisfeld B. S., Dickens S. E. et al. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry: 2000; 61 276 281
79. Altindag A. A case series of increased libido and spontaneous orgasm associated with venlafaxine treatment. Progress Neuropsychopharmacol Biol Psychiatry: 2008; 32 895 896
80. Michael A., Owen A. Venlafaxine-induced increased libido and spontaneous erections. Br J Psychiatry: 1997; 170 193
81. Kilic S., Ergin H., Baydinc Y. C. Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug. Int J Androl: 2005; 28 47 52
82. Zahariou A., Papaioannou P., Karagiannis G. The efficacy of duloxetine in the treatment of premature ejaculation. Int Urol Nephrol: 2007; 39 115 118
83. Hirschfeld R. M., Vornik L. A. Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine. J Clin Psychiatry: 2004; 65 46 52
84. Clayton A., Kornstein S., Prakash A. et al. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med: 2007; 4 917 929
85. Delgado P. L., Brannan S. K., Mallinckrodt C. H. et al. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry: 2005; 66 686 692
86. Nelson J. C., Pritchett Y. L., Martynorv O. et al. The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials. Prim Care Companion J Clin Psychiatry: 2006; 8 212 219
87. Behnke K., Sogaard J., Martin S. et al. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. J Clin Psychopharmacol: 2003; 23 358 364
88. Boyarsky B. K., Haque W., Rouleau M. R. et al. Sexual functioning in depressed outpatients taking mirtazapine. Depress Anxiety: 1999; 9 175 179
89. Labbate L. A. Psychotropics and sexual dysfunction: the evidence and treatments. Adv Psychosom Med: 2008; 29 107 130
90. Saiz-Ruiz J., Montes J. M., Ibanez A. et al. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study. Hum Psychopharmacol: 2005; 20 435 440
91. Gelenberg A. J., McGahuey C., Laukes C. et al. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry: 2000; 61 356 369
92. Versiani M., Moreno R., Ramakers-van Moorsel CJ A. et al. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. CNS Drugs: 2005; 19 137 146
93. Wade A., Crawford G. M., Angus M. et al. A randomised, double-blind, 24-weekstudy comparing the efficacy and tolerability of mirtazepine and paroxetine in depressed patients in primary care. Int Clin Psychopharmacol: 2003; 18 133 141
94. Farah A. Relief of SSRI-induced sexual dysfunction with mirtazapine treatment. J Clin Psychiatry: 1999; 60 260 261
95. Modell J. G., Katholi C. R., Modell J. D. et al. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther: 1997; 61 476 487
96. Dobkin R. D., Menza M., Marin H. et al. Bupropion improves sexual functioning in depressed minority women: an open-label switch study. J Clin Psychopharmacol: 2006; 26 21 26
97. Gardner E. A., Johnston J. A. Bupropion: an antidepressant without sexual pathophysiological action. J Clin Psychopharmacol: 1985; 5 24 29
98. Safarinejad M. R., Hosseini S. Y., Asgari M. A. et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. BJU Int: 2010; 106 832 839
99. Segraves R. T., Croft H., Kavoussi R. et al. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in non depressed women. J Sex Marital Ther: 2001; 27 303 316
100. Crenshaw T. L., Goldberg J. P., Stern W. C. Pharmacologic modification of psychosexual dysfunction. J Sex Marital Ther: 1987; 13 239 252
101. Gitlin M. J., Suri R., Altshuler L. et al. Bupropion-sustained release as a treatment for SSRI-induced sexual side effects. J Sex Marital Ther: 2002; 28 131 138
102. Norden M. J. Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Depression: 1994; 12 109 112
103. Safarinejad M. R. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. BJU Int: 2010; 106 840 847
104. Safarinejad M. R. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. J Psychopharmacol: 2011; 25 370 378
105. Thase M. E., Haight B. R., Richard N. et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry: 2005; 66 974 981
106. Dhillon S., Yang L. P., Curran M. P. Spotlight on bupropion in major depressive disorder. CNS Drugs: 2008; 22 613 617
107. Dhillon S., Yang LP H., Curran M. P. Bupropion. A review of its use in the management of major depressive disorder. Drugs: 2008; 68 653 689
108. Calandra C., Terranova F., Loiacono P. et al. Bupropione nel trattamento del disturbo depressivo maggiore: confronto con paroxetina. Giornale Italiano di Psicopatologia: 2010; 16 128 133
109. Clayton A. H., Croft H. A., Horrigan J. P. et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry: 2006; 67 736 746
110. Coleman C., King B., Bolden-Watson C. et al. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Therapeutics: 2001; 23 1040 1058
111. Walker P. W., Cole J. O., Gardner E. A. et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry: 1993; 54 459 465
112. Croft H., Settle E., Houser T. et al. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther: 1999; 21 643 658
113. Coleman C. C., Cunningham L. A., Foster V. G. et al. Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry: 1999; 11 205 215
114. Thase M. E., Clayton A. H., Haight B. R. et al. A double-blind comparison between bupropion XL and venlafaxine XR. Sexual functioning, antidepressant efficacy and tolerability. J Clin Psychoparmacol: 2006; 26 482 488
115. Baldwin D. S. Sexual dysfunction associated with antidepressant drugs. Expert Opin Drug Saf: 2004; 3 457 470
116. Vanderkooy J. D., Kennedy S. H., Bagby R. M. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry: 2002; 47 174 180
117. Philipp M., Kohnen R., Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol: 1993; 7 149 153
118. Ramasubbu R. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression. J Psychiatry Neurosci: 1999; 24 45 50
119. Yeragani V. K., Gershon S. Priapism related to phenelzine therapy. N Eng J Med: 1987; 317 117 118
120. Margolese H. C., Assalian P. Sexual side effects of antidepressants: a review. J Sex Marital Ther: 1996; 22 209 217
121. Culpepper L., Kovalick L. J. A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression. Prim Care Companion J Clin Psychiatry: 2008; 10 25 30
122. Feiger A., Kiev A., Shrivastava R. K. et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry: 1996; 57 53 62
123. Ferguson J. M., Shrivastava R. K., Stahl S. M. et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry: 2001; 62 24 29
124. Waldinger M. D., Zwindermann A. H., Olivier B. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline and nafazodone. J Clin Psychopharmacol: 2001; 21 293 297
125. Micheal A., Ramana R. Nefazodone-induced spontaneous ejaculation. Br J Psychiatry: 1996; 169 672 673
126. Gartrell N. Increased libido in women receiving trazodone. Am J Psychiatry: 1986; 143 781 782
127. Sullivan G. Increased libido in three man treated with trazodone. J Clin Psychiatry: 1988; 49 202 203
128. Warner M. D., Peabody C. A., Whiteford H. A. et al. Trazodone and priapism. J Clin Psychiatry: 1987; 48 244 245
129. Kennedy S. H. Favorable sexual profile of agomelatine in depressed patients. Eur Neuropsychopharmacol: 2006; 16 S 319
130. Kennedy S. H., Rizvi S., Fulton K. et al. A Double-blind comparison of sexual functioning, antidepressant efficacy and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol: 2008; 28 329 333
131. Montejo A. L., Prieto N., Terleira A. et al. Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale. J Psychopharmacol: 2010; 1 111 120
132. Atmaca M., Kuloglu M., Tezcan E. et al. Switching to tianeptine in patients with antidepressant induced sexual dysfunction. Hum Psychopharmacol Clin Exp: 2003; 18 277 280
133. Dording C. M., Mischoulon D., Shyu I. et al. SAMe and sexual functioning. Eur Psychiatry: 2012; 27 391 476
134. Fabre L. F., Clayton A. H., Smith L. C. et al. The effect of gepirone-ER in the treatment of sexual dysfunction in depressed men. J Sex Med: 2012; 9 821 829
135. Clayton A. H., Kennedy S. H., Edwards J. B. et al. The effect of vilazodone on sexual function during the treatment of major depressive disorder. J Sex Med: 2012; published online: 2012 DEC 6, 10.1111/jsm.12004
136. Basson R., Berman J., Burnett A. et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol: 2000; 163 888 893
137. National Institutes of Health (NIH) NIH Consensus development panel on impotence. JAMA. 1993; 270 83 90
138. Balon R. The DSM criteria of sexual dysfunction: need for a change. J Sex Marital Ther: 2008; 34 186 197
139. Balon R., Segraves R. T., Clayton A. Issues for DSM-V: sexual dysfunction, disorder, or variation along normal distribution: toward rethinking DSM criteria of sexual dysfunctions. Am J Psychiatry: 2007; 164 198 200
140. American Psychiatric Association DSM 5 Devolepment. Available on line at. http://www.dsm5.org/Pages/Default.aspx (latest access on 2010 September 14)
141. Bonierbale M., Lançon C., Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin: 2003; 19 114 124
142. Serretti A., Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol: 2011; 26 130 140
143. Serretti A., Chiesa A. Sexual side effects of pharmacological treatment of psychiatric diseases. Clin Pharmacol Ther: 2011; 89 142 147
144. Zemishlany Z., Weizman A. The impact of mental illness on sexual dysfunction. Adv Psychosom Med: 2008; 29 89 106
145. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol: 1998; 13 S1 S4
146. Chen K. C., Yang Y. K., Lee I. H. et al. Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan. Depress Anxiety: 2008; 25 E56 E62
147. Cohen S., Kühn K-U, Bender S. et al. Sexual impairment in psychiatric inpatients: focus on depression. Pharmacopsychiatry: 2007; 40 58 63
148. Balon R., Segraves R. T. Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants. J Sex Marital Ther: 2008; 34 353 365
149. Rudkin L., Taylor M. J., Hawton KK E. Strategies for managing sexual dysfunction induced by antidepressant medication (protocol). The Cochrane Database of Systematic Reviews: 2002; Issue 4. Art. No.: CD003382. 10.1002/14651858.CD003382
150. Clayton A. H., Montejo A. L. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry: 2006; 67 33 37
151. Michelson D., Bancroft J., Targum S. et al. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry: 2000; 157 239 243
152. Wheatley D. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol: 2004; 19 545 548
153. Dording C. M., Fisher L., Papakostas G. et al. A double-blind, randomized, pilot dose-finding study of maca root (L.Meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapeutics: 2008; 14 182 191
154. Modabbernia A., Sohrabi H., Nasehi A. A. et al. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology: 2012; 223 381 388
155. Clayton A. H., Warnock J. K., Kornstein S. G. et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry: 2004; 65 62 67
156. Baldwin D. S., Palazzo M. C., Masdrakis V. G. Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants. Depress Res Treat. 2013; http://dx.doi.org/10.1155/2013/256841
157. Zajecka J. Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry: 2001; 62 35 43